SCHEMBL15908402

CC(=O)NC1[C@H](O[C@@H]2C(O)[C@H](O[C@@H]3C(CO)O[C@@H](O)C(O)[C@H]3O)OC(CO)[C@@H]2O)OC(CO[C@@H]2OC(CO)[C@@H](O[C@@H]3OC(CO)[C@H](O)[C@H](O)C3O)[C@H](O)C2O)[C@@H](O[C@@H]2O[C@@H](CO)[C@H](O)C(O[C@]3(C(=O)O)C[C@@H](N)[C@@H](C)C([C@H](O)[C@H](O)CO)O3)C2O)[C@@H]1O

nearest known ligand 0.58

Predicted protein targets (top 5)

	gene	UniProt	supporting neighbours	confidence
▸	SIGLEC7	Q9Y286	6/20	0.57

▸	MAG	P20916	8/20	0.53

▸	SELP	P16109	2/20	0.52

▸	SELL	P14151	1/20	0.52

▸	SELE	P16581	3/20	0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL10038947	0.94	SIGLEC7 (0.61)	SIGLEC7MAGSELPSELLSELE
SCHEMBL18365054	0.94	SIGLEC7 (0.61)	SIGLEC7MAGSELPSELLSELE
SCHEMBL16591478	0.94	SIGLEC7 (0.61)	SIGLEC7MAGSELPSELLSELE
SCHEMBL31700342	0.89	SIGLEC7 (0.69)	SIGLEC7MAGSELPSELLSELE
SCHEMBL31701546	0.89	SIGLEC7 (0.69)	SIGLEC7MAGSELPSELLSELE
SCHEMBL31700318	0.89	SIGLEC7 (0.69)	SIGLEC7MAGSELPSELLSELE
SCHEMBL25964211	0.88	SIGLEC7 (0.60)	SIGLEC7MAGSELPSELLSELE
SCHEMBL30650978	0.88	SIGLEC7 (0.70)	SIGLEC7MAGSELPSELLSELE
SCHEMBL25964215	0.87	SIGLEC7 (0.61)	SIGLEC7MAGSELPSELLSELE
SCHEMBL17461351	0.87	SIGLEC7 (0.58)	SIGLEC7MAGSELPSELLSELE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-9446144-B2	Glycopeptide and uses thereof	UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US)	2016-09-20	—	—	US	disclosed
US-20140212473-A1	GLYCOPEPTIDE AND USES THEREOF	UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US)	2014-07-31	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20140212473-A1	GLYCOPEPTIDE AND USES THEREOF	LGALS3BP, SIGLEC7, LNPEP	SIGLEC7 2/4885MAG 52/4885SELP 97/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.